GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Vyome Holdings Inc
The shares of Reshape, a medical device company producing weight loss devices, reflect the demand for obesity solutions. Their price trajectory depends on competition from new drugs and the effectiveness of their products.
Share prices of companies in the market segment - Pharma immune
ReShape Lifesciences is a medical technology company offering comprehensive solutions to combat obesity, including gastric balloons and a telemedicine platform. We've categorized it as "Pharma: Immunology." The chart below shows the dynamics of the bariatric medicine sector.
Broad Market Index - GURU.Markets
ReShape Lifesciences is a medical company offering a portfolio of obesity-related products and services, including gastric balloons. It is a component of the GURU.Markets index. The chart below represents the market. See how this stock compares to the bariatric sector.
Change in the price of a company, segment, and market as a whole per day
HIND - Daily change in the company's share price Vyome Holdings Inc
For Vyome Holdings Inc., a pharmaceutical company, daily volatility reflects sensitivity to scientific data. This metric is an important component in formulas that assess the risks and potential of companies in the biotech sector.
Daily change in the price of a set of shares in a market segment - Pharma immune
Reshape Lifesciences (HIND) offers a portfolio of obesity-related products and services, including gastric balloons. The weight-loss medical device sector is competitive and innovative. The chart below shows the volatility in this niche, allowing us to assess HIND's performance against its peers.
Daily change in the price of a broad market stock, index - GURU.Markets
Vyome Holdings is a biotech company focused on immunology. Its shares, like many in the sector, are highly volatile and react to news about clinical trials. These science-driven movements are part of the complex and diverse landscape of the entire stock market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Vyome Holdings Inc
The year-over-year performance of Vyome Holdings, which operates under the Reshape Lifesciences brand, tells the story of its obesity-fighting product portfolio. Its market capitalization change over the past 12 months reflects both sales of its gastric balloon and progress in developing new technologies, as well as its adaptation to the emergence of new, highly effective weight-loss medications.
Annual dynamics of market capitalization of the market segment - Pharma immune
Reshape, as a company offering weight loss solutions, is a bet on the fight against obesity. Its performance relative to the sector will reveal how much investors believe in its ability to commercialize its products and compete with pharmaceutical giants in this vast market.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
ReShape Lifesciences (HIND), with its obesity-fighting products, reflects the demand for weight-loss solutions. Its performance, compared to the market, reflects the competition between medical devices and pharmaceuticals and the company's ability to effectively market its products to doctors and patients.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Vyome Holdings Inc
Vyome (HIND) is a biopharmaceutical company focused on dermatology. Its monthly performance is entirely dependent on progress in its clinical programs. News of its acne drug trial results is a key driver.
Monthly dynamics of market capitalization of the market segment - Pharma immune
The weight-loss medical device sector is a market where demand is driven by the global obesity problem. Its market capitalization dynamics, shown in the graph, reflect this trend. Companies like Reshape Lifesciences are offering innovative solutions in this area.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Vyome (Reshape) is likely a biotech or healthcare company. Its shares are caught up in the world of clinical data and regulatory news. Their movements are unrelated to the broader market and are a bet on the success of a specific product or technology.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Vyome Holdings Inc
Vyome Holdings, a biotech company focused on treating immune diseases, exhibits high volatility. Its weekly share price performance is a direct response to the release of clinical trial data, which is a key factor in assessing its prospects.
Weekly dynamics of market capitalization of the market segment - Pharma immune
Vyome Holdings (formerly Reshape) is focused on developing drugs for the treatment of skin diseases. Its short-term performance is closely tied to clinical trial results and the commercial success of its products. Comparison with the sector will reveal whether investors are responding to the specifics of dermatology or to general trends in the pharmaceutical industry.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Vyome (Reshape) focuses on drugs for the treatment of skin diseases. Its short-term performance is closely tied to clinical trial results. A comparison with the market will show whether investors are reacting to the specifics of dermatology or to general trends.
Market capitalization of the company, segment and market as a whole
HIND - Market capitalization of the company Vyome Holdings Inc
The market capitalization chart for Vyome Holdings (formerly Reshape Lifesciences) reflects investor valuations of its medical devices for treating obesity. Its extremely low valuation reflects the commercial failures of its previous products, such as the gastric balloon. The current market capitalization is a bet on its new developments in dermatology following the merger.
HIND - Share of the company's market capitalization Vyome Holdings Inc within the market segment - Pharma immune
Vyome Holdings (formerly Reshape Lifesciences) is a company focused on weight loss products. Its market share in the medical technology sector is small, but it offers both surgical and non-surgical solutions. Its market capitalization reflects its product portfolio, including gastric balloons and a telemedicine platform.
Market capitalization of the market segment - Pharma immune
This chart shows the overall value of the entire biotech sector specializing in immune therapy. For Vyome (formerly Reshape), a company working in this field, this line is a map of the future of medicine. The chart's rise reflects investors' belief that modulating the immune system is the key to treating the most complex diseases.
Market capitalization of all companies included in a broad market index - GURU.Markets
Vyome Holdings develops drugs to treat immune-inflammatory diseases. Its market capitalization reflects its scientific pipeline and potential to help patients with chronic inflammation.
Book value capitalization of the company, segment and market as a whole
HIND - Book value capitalization of the company Vyome Holdings Inc
Vyome Holdings is a pharmaceutical company, and its book value is its financial resources for research. This consists of cash that allows the company to pursue its research in dermatology and immunology. How has this research capital changed? The chart below shows.
HIND - Share of the company's book capitalization Vyome Holdings Inc within the market segment - Pharma immune
Vyome Holdings Inc. is a biopharmaceutical company focused on dermatology. Its scientific developments require a physical base: a laboratory for the creation and testing of new drugs for the treatment of skin diseases. The chart shows the company's share of the physical R&D infrastructure in this specific biopharma segment.
Market segment balance sheet capitalization - Pharma immune
Vyome Holdings is likely a biotech company. Pharmaceuticals, as the chart shows, are knowledge- and capital-intensive. Its capital is intellectual property and R&D infrastructure for clinical trials.
Book value of all companies included in the broad market index - GURU.Markets
Vyome's assets (merged with Reshape) now comprise a portfolio of obesity-fighting products, including gastric balloons and a telemedicine platform. The book value reflects the combined value of these medical technologies, which are aimed at solving a global problem.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Vyome Holdings Inc
Vyome Holdings is a biopharmaceutical company. Its market valuation reflects its pipeline and investors' confidence in its ability to bring them to market. It's a classic biotech story, where future potential is valued far more than current assets.
Market to book capitalization ratio in a market segment - Pharma immune
Vyome Holdings is a pharmaceutical company specializing in the treatment of skin diseases. Its valuation on this chart reflects both sales of existing products and the potential of its development pipeline. Investors are assessing its ability to compete in the dermatology field.
Market to book capitalization ratio for the market as a whole
Vyome Holdings (Reshape) develops solutions to treat obesity. This is a huge market, and the company's market value reflects the expected success of its products. This chart shows how investors value companies focused on solving global lifestyle-related health problems.
Debts of the company, segment and market as a whole
HIND - Company debts Vyome Holdings Inc
Vyome (formerly Reshape), a company developing drugs for skin diseases, is funding its clinical trials with raised capital. This chart illustrates the biotech company's financial strategy as it seeks to bring its developments to market in the competitive field of dermatology.
Market segment debts - Pharma immune
Vyome Holdings (formerly Reshape Lifesciences) is a company focused on developing solutions to treat obesity and metabolic diseases. This chart illustrates how the company, operating in a complex and competitive field, manages its capital to fund its products and clinical trials.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Vyome Holdings Inc
Vyome Holdings (formerly Reshape Lifesciences) develops and markets medical devices for the treatment of obesity, such as gastric balloons. Commercializing such products requires significant investment in clinical trials, approvals, and marketing. This chart shows how the company uses debt to advance its solutions in the bariatric market.
Market segment debt to market segment book capitalization - Pharma immune
Vyome Holdings, associated with Reshape, is a healthcare company, likely in the field of obesity treatment or related fields. This chart shows how the company finances its products and research. It compares its debt load to the market capitalization of the entire medical device or pharmaceutical sector, reflecting its financial risks.
Debt to book value of all companies in the market
Vyome Holdings (through Reshape Lifesciences) offers obesity-fighting products, such as gastric balloons. The weight-loss market is competitive and requires investment in clinical data and marketing. How reliant is the company on debt? This chart of total market debt helps evaluate its financial strategy.
P/E of the company, segment and market as a whole
P/E - Vyome Holdings Inc
Vyome Holdings is a biopharmaceutical company developing drugs to treat immune and inflammatory diseases. This chart reflects speculative investor interest in its research and development. The valuation is highly volatile and depends on news about preclinical and clinical trials.
P/E of the market segment - Pharma immune
Vyome Holdings, formerly known as Reshape Lifesciences, is a company operating in the fields of immunology and pharmaceuticals. Its focus determines its market position. This chart illustrates the average valuation in the immunopharmaceutical sector, where investors evaluate the scientific potential and risks of new drug development.
P/E of the market as a whole
Vyome Holdings Inc., formerly ReShape, is a medical technology company that may be focused on developing products to treat obesity or other metabolic disorders. This chart reflects general trends in the healthcare sector. It helps understand whether HIND is valued as an innovative medical technology company or whether its value moves in tandem with overall market sentiment.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Vyome Holdings Inc
Vyome Holdings, through ReShape Lifesciences, offers a portfolio of obesity-fighting products, including intragastric balloons and the Lap-Band system. This chart illustrates how the market views future demand for medical weight-loss solutions and the commercial success of the company's products amid the growing obesity epidemic.
%20P%2FE%20Vyome%20Holdings%20Inc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Vyome-Holdings-Inc&v=1772689053466 "Chart of the company's future (projected) P/E Vyome Holdings Inc")
Future (projected) P/E of the market segment - Pharma immune
Vyome Holdings (formerly ReShape Lifesciences) focuses on developing treatments for skin conditions, particularly acne. The chart reflects future profit forecasts for the sector, helping to understand how much investors believe in the commercial potential of its developments in the vast dermatology market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20immune&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-immune&v=1772689053493 "Future (projected) P/E graph of the market segment - Pharma immune")
Future (projected) P/E of the market as a whole
Vyome Holdings (formerly Reshape) develops solutions to treat metabolic diseases. This chart of overall risk appetite in the biotech sector shows how willing investors are to fund companies tackling global epidemics like obesity and diabetes, where the market is huge but competition is fierce.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772689053547 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Vyome Holdings Inc
Vyome Holdings Inc. (formerly Reshape Lifesciences) is a company focused on obesity solutions, likely developing or selling medical devices. Its profits depend on the success of these products. This chart shows financial results in the important and complex healthcare sector of metabolic diseases.
Profit of companies in the market segment - Pharma immune
Vyome Holdings Inc., through its subsidiaries, develops solutions for treating skin diseases and obesity. This diversified approach to life sciences represents a significant part of the company's overall profitability in the immunopharmaceuticals sector and related areas, where addressing common health issues could unlock significant markets.
Overall market profit
Vyome Holdings Inc. (formerly Reshape Lifesciences) is a medical technology company. Its success depends on innovation, regulatory approvals, and market acceptance of its products. This process is loosely tied to the general economic cycles reflected in this chart, as it is driven by long-term trends in healthcare.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Vyome Holdings Inc
Vyome Holdings is likely a biopharmaceutical company developing immunological therapies. Its future profitability is entirely dependent on the success of clinical trials and regulatory approvals. This chart reflects analysts' speculative expectations for its research pipeline.
%20profit%20of%20the%20company%20Vyome%20Holdings%20Inc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Vyome-Holdings-Inc&v=1772689053637 "Graph of future (projected) profit of the company Vyome Holdings Inc")
Future (predicted) profit of companies in the market segment - Pharma immune
Vyome Holdings (formerly Reshape Lifesciences) is a biopharmaceutical company developing treatments for skin diseases with a focus on overcoming antimicrobial resistance. Its platform is aimed at creating effective dermatological treatments. This chart shows revenue projections for the immunopharmaceuticals sector, providing context for Vyome's valuation.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20immune&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-immune&v=1772689053660 "Graph of future (predicted) profits of companies in a market segment - Pharma immune")
Future (predicted) profit of the market as a whole
Vyome Holdings Inc (formerly Reshape) is a health tech company likely focused on weight-loss products. Demand for such products is driven by discretionary spending and health trends. This revenue expectation chart reflects consumers' willingness to spend money on improving their appearance and well-being.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772689053683 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Vyome Holdings Inc
Vyome Holdings (formerly Reshape) develops solutions to combat obesity and metabolic diseases. Revenue depends on the success of its products. This chart shows how investors value its portfolio, which includes both medical devices and pharmaceutical developments.
P/S market segment - Pharma immune
Vyome Holdings (formerly Reshape Lifesciences) is a company focused on developing solutions to treat obesity and metabolic diseases. Its portfolio includes both medical devices and pharmaceutical developments. This chart reflects the average revenue estimate for the sector, helping to gauge how the market perceives the company's comprehensive approach to combating obesity.
P/S of the market as a whole
Vyome Holdings is a biopharmaceutical company developing drugs to treat immune-related diseases. This chart highlights that the valuation of such clinical-stage companies is based on the potential of their scientific developments to solve complex medical problems, not on current financial performance.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Vyome Holdings Inc
Vyome Holdings is likely a biopharmaceutical company focused on immunology or dermatology. The company's clinical-stage revenue valuation reflects investor confidence. This chart shows the market's confidence in its scientific developments and the commercial potential of its drug candidates for immune-related diseases.
%20P%2FS%20Vyome%20Holdings%20Inc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Vyome-Holdings-Inc&v=1772689053823 "The graph of the company's future (projected) P/S Vyome Holdings Inc")
Future (projected) P/S of the market segment - Pharma immune
Vyome Holdings, formerly ReShape Lifesciences, is now focused on developing treatments for skin conditions. This chart compares the company's estimated future sales with industry expectations. It shows how investors view its new focus on dermatology and the potential of its pipeline of skin treatment candidates.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20immune&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-immune&v=1772689053846 "Future (projected) P/S market segment graph - Pharma immune")
Future (projected) P/S of the market as a whole
Vyome Holdings, which merged with Reshape Lifesciences, operates in the fields of weight loss solutions and metabolic disease treatment. The company's success depends on demand for its products and services. This graph of investor expectations reflects their view of the vast market for treatments for obesity and related diseases.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772689053848 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Vyome Holdings Inc
For Vyome Holdings (formerly Reshape Lifesciences), this metric reflects revenue from its weight-loss products, such as the gastric balloon. Sales dynamics depend on demand for non-surgical obesity treatments and the success of marketing efforts.
Sales of companies in the market segment - Pharma immune
Vyome Holdings Inc. (formerly Reshape Lifesciences) is focused on developing drugs for the treatment of dermatological diseases. Following the sale of its weight loss business, its future revenue will depend on the success of its dermatological candidates, which is typical for a development-stage biotech company.
Overall market sales
Vyome Holdings Inc., through Reshape Lifesciences, offers products to combat obesity, including gastric balloons. Demand for such solutions is growing alongside the global obesity epidemic. This economic downturn may impact patients' ability to pay for procedures, but fundamental medical need is the company's primary driver.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Vyome Holdings Inc
Vyome Holdings (formerly Reshape Lifesciences) is a company engaged in the development and sale of medical devices and medications. Its revenue depends on the market success of its products. This chart reflects analyst sales expectations, which are an indicator of demand for its medical solutions from patients and physicians.
%20sales%20of%20the%20company%20Vyome%20Holdings%20Inc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Vyome-Holdings-Inc&v=1772689053948 "Schedule of future (projected) sales of the company Vyome Holdings Inc")
Future (projected) sales of companies in the market segment - Pharma immune
Vyome Holdings, through Reshape Lifesciences, offers solutions to combat obesity. This chart shows the forecast for the medical device market. Is demand for minimally invasive weight loss devices growing amid the global obesity epidemic? This determines the overall outlook for the industry.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20immune&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-immune&v=1772689053969 "Schedule of future (projected) sales of companies in the market segment - Pharma immune")
Future (projected) sales of the market as a whole
Vyome Holdings (formerly Reshape) is a pharmaceutical company developing drugs to treat immune and inflammatory diseases. Its prospects depend on clinical trial results and regulatory approval. The overall economic trends reflected in this chart do not impact patient demand for effective treatments.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772689053986 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Vyome Holdings Inc
Vyome Holdings (formerly Reshape Lifesciences) is a company specializing in weight loss products. This chart shows its financial performance in the complex obesity industry. Profitability depends on the success of its medical devices and its ability to effectively compete with pharmaceutical and surgical treatments.
Market segment marginality - Pharma immune
Vyome Holdings Inc., formerly Reshape Lifesciences, is a company focused on medical devices for the treatment of obesity. Its profitability depends on successful sales of its products, their acceptance by physicians and patients, and the competitive environment in the bariatric market. This metric reflects its commercial efforts.
Market marginality as a whole
Vyome Holdings (formerly Reshape) develops products for the treatment of skin diseases. The company's success depends on regulatory approval and market acceptance of its drugs. This overall profitability chart reflects the state of the healthcare system, which influences the pricing and availability of new drugs for patients.
Employees in the company, segment and market as a whole
Number of employees in the company Vyome Holdings Inc
Vyome Holdings (formerly ReShape Lifesciences) focuses on developing drugs to treat gastrointestinal diseases. After selling its bariatric surgery assets, the company rebuilt its team. This chart may reflect this transformation: cutting commercial staff and hiring scientists for a new pharmaceutical division.
Share of the company's employees Vyome Holdings Inc within the market segment - Pharma immune
Vyome Holdings (formerly Reshape Lifesciences) specializes in developing medical devices and drugs to treat obesity and metabolic diseases. This dual strategy requires both engineers and pharmaceutical scientists. This chart shows the company's combined labor force share, reflecting its diversified approach to solving the obesity problem.
Number of employees in the market segment - Pharma immune
Vyome Holdings, through its subsidiary ReShape Lifesciences, offers obesity treatment products, including intragastric balloons and the Lap-Band system. The chart shows employment in the immunopharmaceutical and bariatric sectors. The growing obesity epidemic is creating demand for less invasive weight loss methods than surgery.
Number of employees in the market as a whole
Vyome Holdings (Reshape) develops medical devices for the treatment of obesity and metabolic diseases. Its business operates at the intersection of healthcare and consumer demand for weight loss solutions. This chart illustrates the big picture, and Vyome is an example of a company where job creation is driven by both medical needs and lifestyle trends.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Vyome Holdings Inc (HIND)
Vyome Holdings (HIND/Reshape) is a medical technology company focused on weight loss and metabolic health products, including the Lap-Band system. This chart shows how the market values their product portfolio. It reflects the market value per employee, which is a measure of the value of their brand and IP.
%20of%20the%20company%20Vyome%20Holdings%20Inc%20(HIND)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Vyome-Holdings-Inc-HIND&v=1772689054204 "Chart of market capitalization per employee (in thousands of dollars) of the company Vyome Holdings Inc (HIND)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma immune
Vyome Holdings (HIND), trading as Reshape Lifesciences, offers a portfolio of weight loss products, including gastric balloons. In this area of medicine, this metric reflects both the effectiveness and safety of their solutions. Their high market capitalization per employee may indicate that their products are a sought-after and less invasive alternative to bariatric surgery.
%20by%20market%20segment%20-%20Pharma%20immune&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-immune&v=1772689054231 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma immune")
Market capitalization per employee (in thousands of dollars) for the overall market
Vyome Holdings is a biopharmaceutical company focused on developing drugs for the treatment of immune-inflammatory diseases. Its valuation, like that of other clinical-stage biotechs, is driven by research results. The chart shows a high valuation per employee, as its market cap reflects expectations for the future success of its pipeline.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772689054254 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Vyome Holdings Inc (HIND)
Vyome (Reshape) is a biotech company developing drugs for dermatological diseases. This chart reflects the R&D phase. The negative loss per employee is typical for biotech, reflecting the amount of capital invested in each scientist to conduct clinical trials.
%20Chart%20Vyome%20Holdings%20Inc%20(HIND)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Vyome-Holdings-Inc-HIND&v=1772689054266 "Company Profit Per Employee (in thousands of dollars) Chart Vyome Holdings Inc (HIND)")
Profit per employee (in thousands of dollars) in the market segment - Pharma immune
Vyome Holdings Inc. (formerly Reshape Lifesciences) is a company developing technologies to treat obesity. In the field of medical solutions to combat global health problems, the efficiency per employee reflects the demand for their products. The graph shows how successfully the company commercializes its technologies and generates revenue.
%20in%20the%20market%20segment%20-%20Pharma%20immune&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-immune&v=1772689054275 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma immune")
Profit per employee (in thousands of dollars) for the market as a whole
Vyome Holdings (Reshape) is a medical technology company focused on obesity treatment. They sell FDA-approved solutions, such as a gastric balloon. This is a B2B business for clinics. This chart helps understand how profitable the weight loss medical device business, which requires marketing and physician training, is.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772689054327 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Vyome Holdings Inc (HIND)
Vyome Holdings (formerly Reshape) operates in the pharmaceutical and medical device industries. For such a company, this chart demonstrates the commercial viability of its products. Growing revenue per employee indicates successful marketing, strong demand, and the company's ability to carve out a niche in the healthcare market.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Vyome-Holdings-Inc-HIND&v=1772689054359 "Sales chart per company employee Vyome Holdings Inc (HIND)")
Sales per employee in the market segment - Pharma immune
Vyome Holdings (HIND) (formerly Reshape) is a medical technology company historically known for its gastric banding. Now, after mergers, it's focusing on biotech. This chart shows the average output in the sector. For HIND, this is an indicator of how productive their (likely small) staff is in asset management and R&D.
Sales per employee for the market as a whole
Vyome Holdings (HIND), the owner of Reshape, is in the commercial stage. They sell FDA-approved weight loss systems, including gastric balloons. They are a medical device company. This indicator reflects the effectiveness of their sales and marketing team.
Short shares by company, segment and market as a whole
Shares shorted by company Vyome Holdings Inc (HIND)
Vyome (HIND), formerly Reshape Lifesciences, is a company that historically focused on weight loss products (such as a gastric balloon) and is now focused on dermatology. This chart tracks short positions. Bears short companies with a history of failure and a sudden shift in focus.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Vyome-Holdings-Inc-HIND&v=1772689054409 "Short Shares Chart for the Company Vyome Holdings Inc (HIND)")
Shares shorted by market segment - Pharma immune
Vyome Holdings (HIND), formerly Reshape, is a company specializing in obesity treatments, including gastric balloon technology. This chart shows the overall short position in the medical device sector. It highlights investor concerns about competition from new obesity drugs (Ozempic).
Shares shorted by the overall market
HIND (Vyome) is a biotech company developing immunology therapeutics. Like any clinical-stage player, their survival depends on their ability to raise capital for R&D. This chart illustrates the general market fear. At such times, venture capital from the public market dries up, and HIND shares are sold off due to fears of running out of cash to make it to the finish line.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Vyome Holdings Inc (HIND)
This chart for HIND (ReShape Lifesciences) reflects its existential struggle. The company sells weight-loss devices (Lap-Band) in an era dominated by GLP-1 drugs (Ozempic). Any news that their devices are still in demand, or positive insurance coverage data, triggers a "relief rally" (above 70). But mostly, fear of competition prevails, keeping the oscillator "oversold."
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Vyome-Holdings-Inc-HIND&v=1772689054438 "RSI 14 indicator chart for the company's stock Vyome Holdings Inc (HIND)")
RSI 14 Market Segment - Pharma immune
HIND (ReShape Life Sciences) specializes in obesity management. They offer a portfolio of weight loss solutions, including the Lap-Band gastric banding system and Obalon intragastric balloons. This chart measures the overall momentum in the medical device sector. It helps assess whether the entire segment is overheated amid the hype surrounding weight loss drugs (GLP-1).
RSI 14 for the overall market
Vyome Holdings (HIND) specializes in immunology, a field requiring significant R&D investment. The success of such biotechs depends on scientific progress, but their valuations fluctuate wildly with overall risk appetite. This market "temperature" indicator shows when investors are willing to invest in risky but promising developments (euphoria) or when they panic and flee to cash (oversold).
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast HIND (Vyome Holdings Inc)
ReShape Lifesciences (HIND) is a company specializing in bariatric surgery devices (obesity treatment), including the Lap-Band gastric banding system. This chart shows the speculative average 12-month price target from analysts, reflecting their view on competition from GLP-1 drugs.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-HIND-Vyome-Holdings-Inc&v=1772689054476 "A chart showing analyst consensus forecasts for the expected stock price. HIND (Vyome Holdings Inc)")
The difference between the consensus estimate and the actual stock price HIND (Vyome Holdings Inc)
Vyome (HIND) is a biotech company developing a new generation of treatments for skin conditions (such as acne), including those targeting the microbiome. This chart shows how the current share price differs from the "fair" value predicted by analysts. It reflects their faith in this dermatological R&D.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-HIND-Vyome-Holdings-Inc&v=1772689054482 "A chart showing the difference between the consensus forecast and the actual stock price. HIND (Vyome Holdings Inc)")
Analyst consensus forecast for stock prices by market segment - Pharma immune
Vyome (HIND) is a biotech developing drugs (based on its platform) for the treatment of severe inflammatory skin diseases. This chart reflects analyst expectations across the immunopharmaceutical (and skin) sector. It shows whether experts believe in the success of junior R&D biotechs.
Analysts' consensus forecast for the overall market share price
Vyome Holdings (HIND) is a biotech company specializing in developing drugs to treat immune-inflammatory diseases. This chart shows the overall market "risk appetite." For HIND, a high-risk clinical-stage company, overall market optimism (as shown by the rising chart) is critical for raising capital for R&D.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Vyome Holdings Inc
Vyome (Reshape) is a weight-loss MedTech. Their specialty is non-invasive (no surgery) weight-loss devices, ranging from a gastric balloon (which you swallow) to smart scales (SaaS). This chart is a summary of their D2C model. It reflects their (unprofitable) sales growth and their uphill battle to break into the hypercompetitive weight-loss market.
AKIMA Market Segment Index - Pharma immune
Vyome Holdings (ReShape) offers solutions to combat obesity. Their portfolio includes the FDA-approved Lap-Band gastric balloon and related services. It's a medical approach to weight loss. This chart compares their composite index to the sector, showing how their obesity treatment products compare to other medical technologies.
The AKIM Index for the overall market
Vyome Holdings (ReShape) is a company that merged with ReShape Lifesciences. It develops treatments for obesity and metabolic disorders. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this transformed company in the hot weight loss sector compares to overall trends.
